A sample of the library
See the evidence, not the hype.
Pepacora grades every option by condition, across peptides, Rx and hormones, with current research, what patients and peers report, and the cautions that matter. Here is a public look. The full library of 23 conditions and 100 compounds is for licensed, approved clinics.
In the headlines
The six peptides an FDA panel backed for compounding.
Now under interim HHS enforcement discretion, pharmacies can compound these six on a valid prescription. All six are already in the Pepacora library, graded and cited.
BPC-157
Promotes angiogenesis
TB-500
Promotes cell migration
KPV
Inhibition of NF-kB activation, blocking inflammatory cascade
MOTS-c
Regulates nuclear gene expression, promoting cellular homeostasis.
Semax
Modulates neurotransmitter levels by increasing dopamine and serotonin availability
Epitalon
Synthetic pineal tetrapeptide (Ala-Glu-Asp-Gly) that upregulates hTERT/telomerase to elongate telomeres in normal somatic cells and epigenetically modulates neurogenic gene expression and circadian melatonin signaling.
How it reads one condition
Three kinds of evidence, in one view.
Condition Explorer · MCAS
Starting from the patient's presentation
KPV, NF-κB pathway, does not trigger MRGPRX2 · PMID 19909746
Reduced flushing & GI flares
At 12 weeks · real-world outcomes
For licensed clinicians
Open the full library.
Join the waitlist and, once access opens and your clinic is approved, explore every condition and compound, build protocols, prescribe under your NPI, and the pharmacy fills and ships to the patient.